Objective: Recent studies have demonstrated the therapeutic effectiveness and pharmacologic mechanisms of hyperbaric oxygen therapy (HBOT) in the treatment of a systemic shock state. To elucidate the in vivo role of HBOT during sepsis, we evaluated the effects of HBOT on intestinal mucosal injury and bacterial translocation after lipopolysaccharide challenge.
P ostoperative sepsis and subsequent multiple organ failure (MOF) are among the major fatal complications in digestive surgery. During sepsis, the metabolic demands of the gastrointestinal tract for oxygen may exceed delivery, resulting in part from a relative mucosal hypoperfusion and ischemia. Subsequent mucosal dysfunction has been implicated in the pathogenesis of ongoing sepsis through translocation of bacteria or their products from the gastrointestinal tract into the systemic circulation (1) . Several studies suggest that reduction of splanchnic circulation and consequent oxygen delivery lead to a failure of mucosal barrier function and subsequently to an increase of bacterial translocation (BT) from the gut (2) (3) (4) . In addition to these studies, recently several reports showed that endotoxin has been documented to increase inducible nitric oxide synthase (iNOS) activity and nitric oxide (NO) production, and this increase in NO production has been implicated in endotoxin-induced mucosal injury and BT (5) (6) (7) (8) . Many investigators believe that these are important in the genesis of septic shock and MOF syndrome, and it is important to determine therapeutic modalities to prevent translocation of microorganisms or their products through the intestine.
One promising new therapeutic intervention is hyperbaric oxygen therapy (HBOT), or the intermittent inhalation of 100% oxygen under high pressure. In fact, hyperoxia treatment appeared to play a major role in preserving gut barrier function in a rat septic model (9) . Furthermore, accumulated experiences have provided evidence that HBOT is a useful treatment for many severe human illnesses, and it is used in the management of several types of ischemic tissue injuries. HBOT may be efficacious in treating zymosan-induced experimental shock model (10) , and others (11, 12) showed that the anti-inflammation effects of HBOT could be due to a significant decrease in NOS and myeloperoxi-dase (MPO) activities. In an attempt to prevent organ failure following postoperative sepsis in digestive surgeries, we have been prospectively employing HBOT since 1997 and have found that an imbalance between oxygen demand and delivery potentially improves (13) (14) (15) . Based on the trial results, we learned that HBOT suppressed the progression of gut insufficiency. These experiences led us to examine the effects of HBOT on intestinal mucosal injury and BT during sepsis in vivo, specifically from the viewpoint of molecular biology. In the present study, we report that HBOT altered nuclear factor (NF)-B activation in intestinal tissues and suppressed NO overproduction, the activation of neutrophils, intestinal mucosal injuries, and BT.
MATERIALS AND METHODS

Animals
Male Wistar rats weighing 250 -300 g (10 -12 wks of age) were used in this study. The animals were housed in compliance with good laboratory practice for the protection of experimental animals (constant temperature, 22 Ϯ 2°C; relative humidity, 55 Ϯ 10%; regular alternation light-dark, light 7:00 am to 7:00 pm, water and food, ad libitum). The protocol was approved by the University of Medicine of Kagoshima Animal Care Committee.
Hyperbaric Oxygen Therapy
HBOT was given starting 3 hrs after lipopolysaccharide (LPS) challenge in a cylindrical steel chamber (40 cm diameter ϫ 65 cm length, NHC-TC-460, Nakamura Iron Works, Japan) with thick glass windows allowing for direct observation of animals during treatment and continuous monitoring of pressure of inspired oxygen. Before pressurization, 100% medical oxygen was flushed through the chamber for 4 mins to displace ambient air. Oxygen pressure was then increased at a constant rate to reach a pressure of 2.53 ϫ 10 2 kPa (2.5 absolute atmospheres) in 5 mins. After 60 mins of exposure at 2.53 ϫ 10 2 kPa, animals were decompressed to the normal atmospheric pressure at the same rate as in the compression procedure. The chamber was constantly ventilated at a rate of 4 L/min to avoid carbon dioxide accumulation during pressurization.
Experimental Design
Experiment 1. The first experiment was performed to determine whether HBOT would reduce LPS-induced mortality. The rats were treated intraperitoneally with 24 mg/kg LPS from Escherichia coli 055:B5 (Sigma Chemical, St. Louis, MO). The rats were randomly divided into two groups (12 rats per group) that received either no treatment or HBOT. In our studies, LPS at an intraperitoneal dose Յ20 mg/kg caused 0% mortality in Wistar male rats 24 or 48 hrs after LPS challenge, although the death rate at 24 hrs with 28 mg/kg was 80%. Thus, we chose a sublethal LPS dosage (24 mg/kg) in this experiment, and all rats were observed for 72 hrs to monitor survival. Experiment 2. To examine the molecular biological and pharmacologic mechanisms of HBOT, we chose an LPS dosage (10 mg/kg) in this experiment to maximize our ability to evaluate the effects of HBOT during sepsis. The rats were randomly divided into three groups (39 -47 rats per group). The first group was treated with saline solution (0.9% NaCl) by an intraperitoneal route and served as the control group; the second group was treated with 10 mg/kg of LPS intraperitoneally. The third group received LPS (10 mg/kg by an intraperitoneal route) and HBOT. Rats from each group were anaesthetized with ether at 2, 4, 8, or 12 hrs after receiving either saline or LPS, and a midline laparotomy was performed. Blood samples were collected from the abdominal aorta and portal vein for determination of tumor necrosis factor-alpha (TNF-␣) and nitrite/nitrate concentrations. Then, the ileum was collected for measurement of MPO activities and constitutive NOS (cNOS) and iNOS activities in the intestinal mucosa. The terminal ileum was separately removed from rats at 2, 4, and 6 hrs after saline or LPS challenge for NF-B p65 immunohistochemistry. At 24 hrs after animals received either saline or LPS (10 mg/kg by an intraperitoneal route), the mesenteric lymph nodes (MLN), spleens, and livers from rats in each group were harvested using aseptic techniques for assessment of BT. The terminal ileum was removed for histologic examination. In addition, blood samples and another parts of the ileum were collected for biochemical measurements as described previously.
TNF-␣ Determination
At 2, 4, 8, and 12 hrs after saline or LPS challenge, samples from the abdominal aorta were collected for evaluation of plasma TNF-␣ concentrations. HBOT was given starting 3 hrs after LPS challenge, so no data were collected at the 2 hr time point on the LPSϩHBOT group. The concentration of TNF-␣ was measured using a rat TNF-␣ enzyme-linked immunosorbent assay (Endogen, Woburn, MA) with a detection limit of Ͻ10 pg/mL.
Nitrite/Nitrate Assay
We used plasma nitrite/nitrate concentrations as an indicator of NO production. At 4, 8, 12 , and 24 hrs after saline or LPS challenge, systemic blood samples from the abdominal aorta were collected in syringes containing 100 units of heparin and centrifuged to remove the cellular components. The plasma samples were stored at Ϫ20°C until the assays were performed.
The nitrate in the deproteinized plasma was reduced to nitrite using nitrate reductase, and nitrite was measured with Greiss reagent (a combination of equal amounts of 0.1% naphthyl ethylenediamine dihydrochloride in water and 1% sulfanilamide in 5% H 3 PO 4 ). The absorbance was read at 540 nm and 620 nm with a multiple-well plate reader. Nitrite concentrations were calculated by comparison with the absorbance of a standard solution of sodium nitrite.
NOS Activity
The mucosa of a 10-cm segment from the ileum, taken by scraping with a glass slide, was weighed and homogenized in three volumes of ice-cold buffer (50 mM Tris-Cl, pH 7, 300 mM sucrose, 1 mM dithiothreitol, 100 g/mL phenylmethylsulfonylfluoride, 10 g/mL leupeptin, 10 g/mL soybean trypsin inhibitor, and 2 g/mL aprotinin). The mucosal lysate was subjected to ultracentrifugation at 10,000 ϫ g, at 4°C for 20 mins, and the supernatant was removed and stored at Ϫ80°C before protein extraction and measurement of NOS activity (as described subsequently). Protein concentrations within each homogenate were determined by the Bradford assay with bovine serum albumin as standard (16) . NOS activity was measured according to Chen et al. (17) . The NOS activity in the supernatant (as described previously) was measured by adding 30 L of the supernatant to 70 L of incubation buffer containing 50 mM Bis-Tris propane (pH 7.2), 2 mM L-arginine, 3 mM dithiothreitol, 2 mM reduced nicotinamide adenine dinucleotide phosphate, 4 M tetrahydro-L-biopterinm, and 1 mM CaCl 2 . Samples were incubated at 37°C for 90 mins before termination of the reaction by removing reduced nicotinamide adenine dinucleotide phosphate. The reduced nicotinamide adenine dinucleotide phosphate was removed by incubation with 10 units of lactate dehydrogenase and 5 mM sodium pyruvate at 37°C for 10 mins. Nitrite concentrations in the reaction mixtures were determined spectrophotometrically using Griess reagent. The reaction mixture and Griess reagent were incubated in microtiter plates at room temperature for 20 mins in the dark. Absorbance was read at 540 nm and 620 nm with a multiple-well plate reader. Serial dilutions of sodium nitrite were used to generate standards. The NOS activity in the mucosal homogenate was further characterized by incubation with 1 mM EDTA instead of 1 mM CaCl 2 to determine the Ca 2ϩ -dependence of the enzyme activity. The Ca 2ϩ -dependent activity under these assay conditions was taken as the total NOS (tNOS) activity identified with cNOS activity plus iNOS activity, whereas that not inhibited by the EDTA incubation was taken as the activity of the Ca 2ϩindependent inducible isoform of NOS (iNOS). The cNOS activity was determined by subtracting iNOS activity from tNOS activity.
Myeloperoxidase Activity
MPO activities were determined using a minor modification of the method of Krawisz et al. (18) . For determination, ileal mucosa was scraped off and weighed. Then, the specimens (300 mg) of ileal mucosa were homogenized and centrifuged at 10,000 ϫ g at 4°C for 20 mins. The sediments were combined with 0.5 mL of 0.5 % hexadecyltrimethylammonium bromide in 50 mM phosphate buffer (pH 6.0), sonicated for 1 min, and centrifuged at 10,000 ϫ g at 4°C for 20 mins. The supernatant was assayed for MPO activity. MPO activity was measured spectrophotometrically: 50 L of supernatant was combined with 950 L of 50 mM phosphate buffer (pH 6.0), containing 0.167 mg/mL O-dianisidine hydrochloride and 0.0005% hydrogen peroxide. The change in absorbance at 460 nm was measured with a JASCO, V-530 spectrophotometer (JASCO Corporation, Japan). One unit of MPO activity is defined as that degrading 1 mol of peroxidase per minute at 25°C.
NF-B Immunohistochemistry
To detect nuclear NF-B (p50/p65), the following antibodies were used for immunohistochemical stains: rabbit polyclonal immunoglobulin G to rat NF-B p65 (Santa Cruz Biotechnology), biotinylated secondary antibodies, and peroxidase-conjugated streptavidin (Vector). The NF-B p65 antibody with a 1:150 dilution was used. Sections of paraffinfixed terminal ileum (2-3 m thickness) were deparaffinized with xylene and graded ethanol. Endogenous peroxidase was blocked with 0.3% H 2 O 2 in 60% methanol for 30 mins. For antigen retrieval in the NF-B staining, sections were soaked in a 0.01 M citrate buffer and heated in an autoclave (121°C) for 15 mins. Then, immunohistochemical staining using antibody specific for activated p65 was used following standard ABC techniques using a Vectastain ABC-AP Kit (19) . Sections were incubated with primary antibody overnight at 4°C.
Activation Score
To allow a quantitative analysis of the number of NF-B p65-activated cells in the mucosa, we used an activating score according to a minor modification of the definition of Rogler et al. (20) . Each specimen was observed by light microscopy with a 400-fold magnification after staining of the NF-B p65 antibody, and activated cells were counted in three microscopic fields. Although activated cells were mainly detected both in the lamina propria and in some epithelial cells in the villi, activated cell counts were performed only in the epithelial cells in the villi. The average of the three fields was taken as the activation score of the specimen. 
Histologic Examination
Bacterial Translocation
The collected MLN, spleen, and liver were weighed and homogenized in 10 volumes of sterile saline. Aliquots (100 L) of homogenate from each tissue were plated onto blood and MacConkey agar plates. The plates were examined after 48 hrs of aerobic incubation at 37°C. Representative colonies were expressed as colony-forming units per gram of organ tissue (CFU/g) and converted to log10. For each tissue, positive BT was defined as at least three of five plates with growing bacteria and Ͼ50 CFU/g.
Statistical Analysis
Data are presented as the mean Ϯ SD, and p Ͻ .05 is considered to be statistically significant. TNF-␣ and nitrite/nitrate concentrations, NOS activities, and MPO activities between groups were assessed with one-way analysis of variance, followed by the Bonferroni test. For the results of the grading of mucosal injury, the activation score of NF-B p65, and the number of CFU, the data converted to log10 were evaluated by the Mann-Whitney nonparametric test. Translocation incidence was evaluated by chi-square 2 analysis with the Yates correction. Statistical analysis for survival data were evaluated by the log rank test.
RESULTS
Effect of HBO Treatment on Survival
At the end of the observation period (72 hrs), 67% of the LPS-treated rats were dead. HBOT, however, significantly reduced LPS-induced mortality (25%; Fig. 1 ).
Plasma TNF-␣ Concentration
TNF-␣ is the first mediator of cytokines when stress is added to an organism, and the concentration increases during the early stage of LPS stimulation. The TNF-␣ concentrations were significantly higher in the LPS group than in the control group at 2 and 4 hrs after LPS challenge. HBOT given 3 hrs after LPS challenge did not alter the change in plasma TNF-␣ concentrations (Fig. 2 ).
Suppression of NO Production
There is increasing evidence that NO plays a central role in the physiologic maintenance of normal gut homeostasis as well as in the pathophysiologic response of the intestine to injury and critical illness (22, 23) . The nitrite/nitrate concentrations of the systemic blood, which were effects of endotoxin on the stable end products of NO production, were significantly higher in the rats that received LPS than in the control rats. HBOT significantly reduced NO production at 8, 12, and 24 hrs after LPS challenge (Fig. 3A) .
The levels of cNOS activity were not significantly different among any of the groups at anytime after LPS or saline challenge (data not shown). The iNOS activities were significantly higher in the LPS group than in the control group. HBOT significantly reduced iNOS activity at 4, 8, and 12 hrs after LPS challenge (Fig. 3B ).
Myeloperoxidase Activity
MPO is an enzyme found in neutrophils and, at much lower concentration, in monocytes and macrophages. The level of MPO activity in a suspension of neutrophils is directly proportional to the number of neutrophils present over a wide range of neutrophil concentrations (18) . When LPS was administered intraperitoneally, MPO activities in the ileal mucosa were significantly elevated compared with the control group. However, the elevation of MPO activities was considerably reduced by HBOT (Fig. 4) .
Suppression of NF-B Activation
NF-B is a ubiquitous transcription factor involved in the signal transduction pathway of many inducers of the inflammatory response (24) and is therefore a potentially attractive target for immunomodulation to reduce sepsis and organ failure. LPS activates NF-B in vivo and its activation, in turn, induces transcription of the iNOS gene and expression of the iNOS protein (25) . Nuclear NF-B staining was barely discernible by immunohistochemistry in control animals. Numerous cells in the lamina propria and some epithelial cells in the villi showed strong nuclear staining with anti-p65 antibody (1:150 dilution) after LPS injection without HBOT. With HBOT, the immunostaining of NF-B showed marked attenuation (Fig. 5) . When we used the activation score, the values at 2, 4, and 6 hrs after LPS challenge were significantly higher in the LPS group than in the control group. HBOT significantly reduced the activation score at 6 hrs (74 Ϯ 12 vs. 39 Ϯ 15) after LPS challenge ( Table 1) .
Histologic Analysis
Histologic examination of the terminal ileum showed that loss or necrosis of villi in most of the LPS-challenged rats without HBOT (Fig. 6A) . Rats treated with HBOT show less injury than rats not treated by HBOT (Fig. 6B) .
The control rats injected with saline had a median grade 0 with only a few rats showing grade 1. The median grade of injury in the LPS group was 5 (range, 4 -7) , and that in the LPSϩHBOT group was 4 (range, [3] [4] [5] [6] . The difference between the two groups was statistically significant (Fig. 6C ).
Effect of HBOT on BT
BT did not occur in the control group rats. The incidence of BT after LPS injection tended to be lower in the HBOT group than in the nontreated group, although the results were not statistically significant. On the other hand, the degree of BT of the MLN in the LPSϩHBOT group was significantly reduced compared with the LPS group (Table 2 ).
DISCUSSION
The rationale for using HBOT is the alleviation of tissue hypoxia through the inhalation of high-concentration oxygen under hyperbaric conditions, resulting in increased blood oxygen tension (10-to 20-fold) and also in increased distance of interstitial oxygen diffusion (two to three times) (26) . HBOT has also been shown to reduce vascular endothelial damage through suppression of neutrophil adhesion mediated by inhibition of leukocyte migration and also by blocking the release of adhesion molecules (13, 27) . Moreover, recent experimental studies revealed the therapeutic effectiveness and pharmacologic mechanisms of HBOT in the treatment of a systemic shock state (10, 12, 28) . Hence, beneficial effects of HBOT have been attributed to two mechanisms: a) the HBOT, hyperbaric oxygen therapy. a p Ͻ .001 vs. control group; b p Ͻ .005 vs. LPS group. Data are expressed as mean Ϯ SD for n ϭ 3. There were three microscopic fields in a specimen. No data were collected at the 2-hr time point on the LPS ϩ HBOT group. prevention of failure in tissue oxygen metabolism through an increase in dissolved oxygen and b) the reduction of organ injuries through the inhibition of cytokine induction and the expression of adhesion molecules in the acute injury phase. Recently, in the digestive field, HBOT has been indicated for serious infections (29) , hyperbilirubinemia (14, 15, 30) , Crohn's disease (31) , and ulcerative colitis (32) .
We have examined the effects of HBOT on mucosal injury and BT during sepsis in vivo. In the present study, HBOT attenuated NO overproduction and the accumulation of neutrophils in the intestinal mucosa and prevented intestinal mucosal injuries and BT. In our experiments, the plasma TNF-␣ concentration reached a maximum at 2 hrs after LPS challenge and subsequently decreased. According to some authors (10, 33) , HBOT induced a significant reduction of plasma TNF-␣ concentrations in the zymosan-induced shock model or the intes-tinal ischemia-reperfusion model. In our study, however, HBOT given at 3 hrs after LPS challenge did not affect the plasma TNF-␣ concentrations afterward. Therefore, LPS-induced overproduction of cytokines had already occurred, and we extended our studies to determine the basis of HBOT benefits during sepsis.
Several studies have suggested that low concentrations of NO produced by the cNOS may protect an organ in the early stages of injury, whereas elevated and prolonged NO production by iNOS, which is induced by cytokines or endotoxin during the later stages of the insult, may result in or potentiate organ injury (22, 34) . Others reported that endotoxin challenge was associated with increased blood and tissue (e.g., MLN, liver, and ileum) nitrite/nitrate production and an increase in MLN, liver, and ileal iNOS, but not cNOS activity (5) . Using an iNOS knockout animal model to examine the potential relationship between NO production and endotoxin-induced mucosal injury, these authors also reported that endotoxin-induced gut mucosal injury seems to be mediated through increased NO production by activated iNOS and that selective inhibition of iNOS may be useful in preventing gut barrier failure, which plays a role in sepsis and MOF (6) . Our study shows that intestinal iNOS activity reaches a maximum at 4 hrs after endotoxin challenge and nitrite/nitrate plasma concentrations peak at 12 hrs. In our experience, HBOT was able to reduce mucosal iNOS activities and plasma nitrite/nitrate concentrations. These results are consistent with those of other authors (11) : HBOT significantly decreased NOS activity in mucosa in experimental colitis. In addition, other authors reported that HBOT reduced NO concentrations either in plasma or in peritoneal exudate after zymosan challenge (10) .
HBOT induced a significant reduction in MPO activity in the lungs, small intestine, and liver when administered in the zymosan-induced shock model (35) . In this study, HBOT also induced a significant reduction in MPO activities in the ileal mucosa of an LPS-induced septic rat. Overall, it was verified that HBOT inhibits both mucosal iNOS and MPO activities that induce overproduction of plasma nitrite/nitrate in an LPS-induced sepsis model. These results indicate that mucosal injury and BT were reduced.
Using immunohistochemical analyses, we studied the HBOT-stimulated modification of NF-B (p65) activation in the intestinal mucosa, because the change in serum TNF-␣ concentrations implied that intestinal macrophages, the primary target cell of LPS, were already activated before HBOT. The presence of activated NF-B was shown for the first time in lamina propria macrophages and epithelial cells in the inflamed mucosa of patients with inflammatory bowel disease (20) . Certainly, activated NF-B could be found in lamina propria cells and epithelial cells in the ileal mucosa at 2, 4, and 6 hrs after LPS challenge. Surprisingly, HBOT inhibited the activation of NF-B in the intestinal mucosa caused by LPSinduced cytokine overproduction during the 4 -6 hrs after the LPS injection. Thus, it seems that iNOS activities and iNOSmediated NO overproduction were sequentially inhibited. Moreover, this inhibitory effect on NF-B may suppress the overproduction of chemokines (e.g., interleukin-8) that activate neutrophils. NF-B is known to be a redox-sensitive transcription factor. The contribution of redox regulation and the location of potential redox-sensitive sites within the NF-B activation pathway are subject to intense debate due to many conflicting reports (36 -38) . HBOT may alter the redox state and produce a beneficial response.
Many studies have demonstrated that the prevention of BT might become an important therapeutic tool to lessen the occurrence of infectious complications and MOF syndrome. In the burn-induced injury model, HBOT reduced histologic evidence of mucosal injury that was associated with reduced numbers of animals with bacteria in the mesenteric lymph nodes (39) . Other authors reported that HBOT ameliorates BT in rats with obstructive jaundice, mechanical intestinal obstruction, or thermal injury (40 -42) . In this study, the death of the animals was caused by sepsis, because the dissection of LPS-induced dead animals showed the infiltration of inflammatory cells or morphologic injury in multiple organs. The data from this study show that HBOT preserved the intestinal morphology from endotoxin-induced mucosal injury and protected gut barrier function. Although we did not investigate whether similar molecular biological and morphologic amelioration by HBOT results during a sublethal dosage, the mortality rates appeared to decrease after a sublethal LPS challenge, as shown in the first experiment. Herein, we propose one possible mechanism for these beneficial effects: modification NF-B activation 3 reduction of iNOS and MPO activities 3 preservation of mucosal barrier functions 3 prevention of BT ( Fig. 7) . Of course, the improved oxygen delivery by HBOT can directly contribute to the maintenance of mucosal barrier function. The fact is that LPS administration induced a significant increase in mesenteric lactate concentrations and HBOT reduced the production of lactate after 8 hrs in our experiments (data not shown). 
